Estela Rodriguez/doctors.umiamihealth.org
Jan 28, 2025, 17:24
Estela Rodriguez: Dear FDA, clinical trial diversity is not DEI
Estela Rodriguez, Associate Director of Community Outreach and Co-Lead of the Thoracic Site Disease Group of the Sylvester Comprehensive Cancer Center, shared a post on X:
“Dear U.S. FDA: Clinical trial diversity is not DEI, it is an attempt to make better science to study drugs in communities impacted most by disease.
Politics should not impact this goal. Don’t take us back to a time when Hispanics (19% of the population) are not even included in trials.
‘FDA purges material on clinical trial diversity from its site, showing stakes of Trump DEI ban’ via STAT.”
More posts featuring Estela Rodriguez.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 22, 2025, 05:17
Aug 22, 2025, 05:06
Aug 22, 2025, 04:59